About Author : Mateen Dalal

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switched his professional genre, and now works for intelligencejournal.com and a couple of similar portals, contributing industry-rich articles harnessing his expertise in technology and manufacturing.



Contribution by Mateen Dalal

Roches risdiplam meets primary endpoint results in phase 3 trial

Spinal muscular atrophy (SMA) is a genetic neuromuscular condition, affecting approx. 1 in 6,000 babies born globally each year. Numerous healthcare companies throughout the world are putting their best foot forward to develop an effective ...

Read More >>
Disney+ all set for a March 2020 launch in the United Kingdom

The entertainment behemoth is launching its much-awaited streaming platform.   Release of more than 300 movies is on the cards. Disney has finally asserted that new streaming service Disney+ will be rolled out soon in the U.K. Disney+ goes...

Read More >>
AB Science receives Orphan Drug Designation from the FDA for AB8939

AML (acute myeloid leukemia), a severe, life-threating disease that is one of the most common causes of cancer-related death. Common treatment options for this condition includes stem-cell transplants, chemotherapy and other drug therapy. However, wi...

Read More >>
Adidas collaborates with ISS for product research development in space

  The brand will use microgravity to test its products in the space Adidas will be the first brand to test footwear products outside the earth Adidas reportedly announced that it will ink a multi-year collaboration with the International S...

Read More >>
RigNet enters into strategic agreement with BP for Intelie Live

Intelie Live facilitates visualizations for internal teams to offer real-time operating condition across a broad range of configurations and equipment type.  RigNet, a leading supplier of ultra-secure, intellectual networking solutions, ha...

Read More >>
Tractus Vascular receives 510(k) clearance for its TractusTM CSC

Vascular diseases are commonly termed as any abnormal condition that arises in the blood vessels (veins and arteries) which can lead to severe disability or death. Currently, there are several treatment alternatives for this condition, but sever...

Read More >>
Zoetis acquires veterinary diagnostic service provider Phoenix Lab

Zoetis acquires veterinary diagnostic service provider Phoenix Lab The global veterinary diagnostics market, including point-of-care diagnostics and reference laboratories, is estimated to be worth $4 billion, with a compound annual growth rate of a...

Read More >>
TSI finalizes Phase 2 Study Protocol in Myocardial infarction

Myocardial infarction (MI), commonly known as heart attack, occurs due to decrease in blood flow that damages heart muscles. Currently, MI treatment varies from making changes in lifestyle to medication and bypass surgeries. However, various pha...

Read More >>
FDA BRUDAC panel backs Agile Therapeutics’ Twirla contraceptive patch

Agile Therapeutics, Inc., a renowned New Jersey based women’s healthcare and pharmaceutical company, has reportedly announced the positive outcome of a recent U.S. FDA Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) meeting he...

Read More >>
Fiat Chrysler and PSA Group amid talks for a potential merger

Factors like global economic slowdown as well as increasing shift towards autonomous driving and electrification has forced automakers to join forces and share expenses for product R&D and manufacturing. One such instance was seen recently when ...

Read More >>
Uber set to grow its presence into financial services with Uber Money

Uber is no longer a company that focuses solely on ridesharing services. The company is said to be working on various technologies like urban air transport and self-driving vehicles. It has also ventured into the food delivery sector, helping people ...

Read More >>
UK MHRA assigns PIM status to ReveraGen’s Vamorolone as a DMD therapy

Duchenne muscular dystrophy (DMD) approximately affects 1 in every 3,500 male births every year in the world. several biopharmaceutical and biotechnology firms across the globe are increasingly working towards the discovery and development of novel t...

Read More >>
ASM announces launch of Checksome™ to advance patient safety

Blockchain has grown to become an ingenious invention and has built the backbone for a new type of internet, which is originally devised for digital currencies and bitcoin. However, several tech companies have found other potential for this technolog...

Read More >>
Abeona Therapeutics unveils positive data from trial for RDEB therapy

Various hereditary disorders and diseases are increasingly growing across the world which need to be treated effectively. Global pharmaceutical firms are increasingly working towards finding novel solutions to address the ever-increasing occurrence o...

Read More >>
Sun Pharma unveils CEQUA in the US to treat dry eye disease patients

Leading specialty generic pharmaceutical company Sun Pharmaceutical Industries Ltd has reportedly announced the launch of CEQUA (cyclosporine ophthalmic solution) 0.09% in the US by one of its subsidiaries. The drug will evidently be used to increas...

Read More >>
Topcon partners with IBM for Merge Eye Station and Eye Care PACS users

Ophthalmic device usage and production are projected to witness an exponential growth in the near future due to the growing prevalence of eye conditions. Various pharmaceutical firms across the world are increasingly turning towards the usage of opht...

Read More >>
Gilead, Galapagos reveal FINCH 1 & FINCH 3 trial results of Filgotinib

Autoimmune diseases are on a rise in today’s fast-paced world. Rheumatoid arthritis (RA) is one such clinical condition in which a patient’s immune system attacks its own tissue, including joints. In many cases, the disease ends up a...

Read More >>
US senator pleas investigation over TikTok’s Musical.ly acquisition

Musical.ly is a social media service which was released in 2014 in Shanghai and is incorporated in Santa Monica, California. The service was acquired by ByteDance and has been operating as TikTok for overseas markets. However, the viral social media...

Read More >>
Midatech initiates Phase 1 trial of a new hormonal cancer therapy

Cancer treatment is one of the biggest challenges for the 21st century. There have been many advancements in the field of cancer treatment over the past few years. Clinical trial indeed plays a pivotal role in discovering new drugs, especially for tr...

Read More >>
DISH Network inks Multi-Year Carriage Agreement with Fox Corp.

Sports channels are one of the few types of TV broadcasts that people prefer live. No channel is more vital to sports fans than a regional sports network that views their favorite teams. However, a dispute emerged recently between Dish Network and Fo...

Read More >>
Zydus reveals positive data from EVIDENCES IV phase 2 clinical trial

Non-alcoholic Steatohepatitis (NASH) is a progressive disease which can ultimately lead to cirrhosis and liver failure. Liver transplantation is the only treatment for managing advanced cirrhosis with liver failure. There are currently no U.S. Food a...

Read More >>
Noxxon reveals results from PHASE 1/2 trial of NOX-A12/KEYTRUDA®

Colorectal cancer (CRC), also known as bowel or colon cancer, is a type of cancer that involves abnormal growth of cells that can invade or spread to other parts of the body. Growing prevalence of CRC has led various pharmaceuticals firms t...

Read More >>
CVS Pharmacy suspends sale of Zantac and CVS brand ranitidine products

Lately, Carcinogens have found their way into the generic drug supply of the United States. In 2018, FDA found NDMA, a probable carcinogen for humans, in the widely-used valsartan tablets due to the impurities it had in it.  A similar case deve...

Read More >>
GM to feature Alexa in its vehicles to control the infotainment system

Modern vehicle infotainment systems are more complex than ever, with numerous features like maps, social media access as well as video streaming from different platforms, these systems are no less than a smartphone. Today, these systems use AI to int...

Read More >>
Salarius obtains dose-escalation milestones for its Seclidemstat trial

sarcoma is a type of bone cancer that can also appear in fat, muscle, deep skin tissues, blood vessels, tendons, ligaments and cartilage. Moreover, there are over 70 types of sarcoma, with each treatment varying from the other, depending on...

Read More >>
Ipsen reveals promising results from a Phase IIIb/IV ENGAGE trial

limb spasticity is a disorder that hampers the movement of the arms by stiffing the muscles. Spasticity is a result of the body’s damaged nervous system, which generally occurs due to disease, injury or stroke. Several pharma com...

Read More >>
FreightCar America forms new railcar production JV with Fasemex

Despite ongoing geopolitical tensions, Mexico is still the primary trading partner for the United States. Owing to the wide-scale presence of skilled and affordable workforce, Mexico is ideal for enterprises looking to optimize operations and attain ...

Read More >>
Knopp posts data of KB-3061 working on KCNQ2 Epileptic Encephalopathy

KCNQ2 epileptic encephalopathies is a serious type of neonatal epileptic condition which manifests in newborn children during the first week if their lives. This disease is being addressed by various pharmaceutical companies across the globe trying t...

Read More >>
Novo Nordisk and Medtronic team up to offer digital diabetes solutions

With growing population of diabetic patients, diabetes management is becoming a daunting activity. Sugar level management and insulin injections tracking is a difficult work. Thus, leading pharmaceutical companies are collaborating with medical devic...

Read More >>
Akesis unveils its advanced Galaxy™ RTi and Gemini360 at ASTRO 2019

The healthcare company will showcase its drugs in the ASTRO annual meeting 2019 that could help offer improved efficiency and confidence in treatment delivery. Akesis, Inc., a hospital and healthcare company based in the U.S. that offers innovative...

Read More >>
Adverum reveals positive results from Phase 1 trial of ADVM-022

The drug was well tolerated and was safe, and has shown the capacity to improve the treatment paradigm for patients with wet AMD. Adverum Biotechnologies, Inc., a company that develops medical therapies for ocular and rare diseases, recently announc...

Read More >>
Apple initiates new medical studies focusing on various health issues

The company plans to join various institutions in order to accomplish its new medical studies which focus on hearing, women’s health and mobility. Apple Inc., a multinational tech company, has recently announced that it is planning to run ...

Read More >>
Ford to launch eight new electric vehicles across Europe this year

Electric variants of the company’s Puma and Kuga SUVs as well as the Mondeo sedan will be the new launches in Europe.   The company also plans to unveil nine more electric vehicles across Europe by 2024. Ford Motor Co, American multi...

Read More >>
Coca-Cola Amatil unifies its alcohol, coffee & soft drinks businesses

The company’s Australian business will return to growth in 2020 and will likely help realize its mid-single-digit profit growth targets. Coca-Cola Amatil Ltd. (CCA), the leading bottlers of ready-to-drink non-alcoholic beverages, is ...

Read More >>
Prudential plans to acquire U.S. based tech startup Assurance IQ

The insurance company has signed a deal with Assurance IQ for $2.35 billion and is willing to pay extra $1.15 billion in equity and cash. Prudential Financial, Inc., a Fortune 500 company that offers investment management, insurance and other financ...

Read More >>
Inhibrx enrolls its first patient of Phase 1 trial of INBRX-101

INBRX-101 is built to provide greater clinical activity to pdAAT by offering sustained improved concentration of plasma within a less frequent, regimen of monthly dosing.     Inhibrx anticipates to unveil preliminary functional ph...

Read More >>
Sony plans to release next-generation of NUCLeUS for hospitals

The electronics giant is looking forward to putting forth the next-generation of its Smart Imaging Platform to offer hospitals a streamlined digital imaging work-flow. Sony, the leader in electronics for the professional and consumer markets, report...

Read More >>
Telix Pharmaceuticals announces launch of Renal cancer imaging study

The pharmaceutical company declared the completion of CTN submission to Japanese PMDA for TLX250-CDx. It is permitted to conduct Phase trials for renal cancer patients. Australia based clinical-stage biopharmaceutical firm Telix Pharmaceuticals ...

Read More >>
Bio-Path begins patient dosing in amended Phase 2 Prexigebersen trial

The trial focuses on the effects of Prexigebersen when combined with Decitabine and Venetoclax on AML patients. Bio-Path Holdings, Inc., a biotechnology company renowned for creating therapeutic nucleic acid anticancer drugs, has recently announced ...

Read More >>
CStone announces 1st dosed patient in China for advanced GIST trial

Leading biopharmaceutical expert CStone Pharmaceuticals has reportedly announced the first person in China to be dosed for the Phase I/II bridging trial of Avapritinib, discovered by Blueprint Medicines, a partner of CStone. This China-based standal...

Read More >>
Veeva, MuleSoft launch MuleSoft Connector for Veeva Vault

The latest product integration would bolster Veeva’s track record of innovation for joint Salesforce customers. Veeva Systems Inc., a cloud-computing company that focuses on life sciences industry, and MuleSoft, LLC. have recently developed&nb...

Read More >>
MoA Technology targets herbicide resistance crisis & raises $8 million

MoA Technology has created three platforms: MoA SELECTTM, MoA TARGETTM and MoA GALAXYTM, which would work together for effective herbicide creation.   MoA Technology is borne out of Oxford University research is aimed at inhibiting herbicide...

Read More >>
Trump refuses to forge deals with Huawei citing national security

Donald Trump declares the business with Huawei as a national threat and hence forth has declined all the business opportunities with the company.   The existing contract of the Commerce Department is expected to end sooner. The United Stat...

Read More >>
Trovagene to unveil key study data at APAC Prostate Cancer Conference

Data from the Phase 2 Onvansertib clinical trial will be presented at the 20th Prostate Cancer Conference.   The trial assesses the efficacies of Onvansertib on patients with Metastatic Castration-Resistant Prostate Cancer. Trovagene, a cl...

Read More >>
Amazon India unveils Marketplace Appstore to offer business solutions

The platform would allow sellers to search for applications that help them automate, grow and manage their business as well as connect developers with retailers. E-commerce giant, Amazon.com, Inc. has recently unveiled The Amazon Marketplace Ap...

Read More >>
Lenovo launches new ThinkSystem SR635 & SR655 single-socket servers

The new servers will offer businesses with performance of a dual-socket server at the price of a single-socket. Chinese multinational conglomerate, Lenovo has recently revealed its new ThinkSystem SR655 and SR635 server platforms, two of the most p...

Read More >>
Novartis backs Zolgensma® to treat spinal muscular atrophy in children

Zolgensma is specifically designed to be given to children below the age of two years with SMA.   The FDA acknowledged that there were data integrity issues with Zolgensma’s Biologics License Application. The U.S. Food and Drug Admin...

Read More >>
Alkahest reveals positive outcomes from Phase 2 study of GRF6019

The study cites that dosing with GRF6019 were harmless and well-tolerated in patients with Alzheimer’s disease dementia (AD). Alkahest, Inc., a clinical-stage biopharmaceutical company focused on researching and creating transformative therapi...

Read More >>
Precigen Inc. doses first patient in study of advanced cancer therapy

PRGN-3005 UltraCAR-T is a type of multigenic CAR-T cell therapy which utilizes Precigens advanced non-viral gene delivery system Precigen Inc, a biopharmaceutical company and a wholly owned subsidiary of Intrexon Corporation, has recently confirmed ...

Read More >>
SELLAS doses first patient in study of GPS and KEYTRUDA® combination

The trial involves patients diagnosed with acute myeloid leukemia and colorectal, ovarian, triple negative breast and small cell lung cancers. SELLAS Life Sciences Group, Inc., a biopharmaceutical company focusing on the development of cancer immun...

Read More >>
U.S. National Telemedicine debuts telehealth service DocTalkGo

DocTalkGo is a third-party tool which provides various telemedicine healthcare options in the U.S. Sole telemedicine weight loss entity of U.S. has recently launched a telehealthcare service dubbed DocTalkGo. According to sources, the platform aims ...

Read More >>
nVent to acquire Eldon Enclosures business for USD 130 million

nVent plans to augment digital and modular capabilities to provide customers with customizable solutions with the new acquisition. UK-based nVent Electric company, a global leader in innovative electrical solutions, recently announced having entered...

Read More >>
Pfizer plans to merge with Mylan, will create an off-patent drug giant

Mylan holds a market value worth $9.5 billion and has witnessed almost 50% fall in its shares over the last year Pfizer Inc., a multinational pharmaceutical company based in America, reportedly plans to combine its off-patent unit, that includes Via...

Read More >>
Merck unveils Phase 2b results of investigational HIV-1 therapy

New findings come from evaluation of Doravirine combined with Islatravir versus DELSTRIGO.   The company plans to start Phase 3 trials soon. Merck & Co., (Merck), a leading biopharmaceutical company known as MSD across the globe except...

Read More >>
Ascentage to commence U.S. trials of HQP1351 in TKI resistant leukemia

The Phase 1b clinical trial can accelerate HQP1351’s clinical development program globally Ascentage Pharma, a biotechnology company that is involved in the development of novel therapies for hepatitis B virus, age-related diseases and cancers...

Read More >>
Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial

Ambrx will receive additional development payments with Bristol-Meyers’ initiation of the Phase 1 clinical trial for Relaxin Ambrx Inc., a biopharmaceutical company focused on developing protein therapeutics, has recently announced that Bristo...

Read More >>
LifeSpan Bio acquires Everest Biotech to expand reagent portfolio

The transaction will be LifeSpan BioSciences’ second investment this year following its Nordic-MUbio acquisition LifeSpan BioSciences (LSBio), a provider of life science research reagents and antibodies, has recently announced that it has acqu...

Read More >>
AbbVie buys Mavupharma to target STING pathway for cancer treatment

AbbVie Inc., a US-based pharmaceutical company recently announced acquisition of Mavupharma, a Seattle-based biopharmaceutical company, which is focused on innovative strategies to target the STimulator of INterferon Genes pathway for the treatment o...

Read More >>
Motorola Solutions buys WatchGuard to expand video security portfolio

WatchGuard’s solutions allow law enforcement users to manage high-quality video evidence Motorola Solutions, Inc., the US based data communications and telecommunications equipment provider, has recently announced the acquisition of WatchGuard...

Read More >>
Cara begins Phase 2 trial of pruritus treatment in dermatitis patients

The study is formulated to evaluate the safety and efficacy of Oral KORSUVA for moderate to severe pruritus Biopharmaceutical firm Cara Therapeutics Inc. has reportedly announced the initiation of their Phase 2 trial of Oral KORSUVATM for pruritus t...

Read More >>
Prestige BioPharma inks two new deals for its biosimilar trastuzumab

The company would be able to supply and commercialize its biosimilar across Russia under the latest of the two deals.   The second deal, meanwhile, gives Prestige access to certain parts of Europe. Prestige BioPharma (Prestige), a renowned...

Read More >>
Froneri to acquire Noga Ice Creams from Nestle owned Osem Group

Though financial details about the deal have not been disclosed, experts opine that it will amount to tens of millions of euros. Froneri, the renowned ice cream manufacturer, reportedly entered the Israeli market by acquiring Noga Ice Creams Limited...

Read More >>
Onco360® to be specialty pharmacy partner for Karyopharm’s XPOVIO™

Onco360 will be able to support specialized needs of RRMM patients and their physicians across all the U.S. states The largest independent oncology pharmacy in U.S., Onco360 recently announced that Karyopharm has selected the company as a new specia...

Read More >>
Iovance Bio updates cervical cancer program data post FDA meeting

The innovaTIL-04 study is anticipated to register a total of 75 to 100 patients with the aim to support a BLA submission Reports confirm that Iovance Biotherapeutics, Inc., a biotech company, has recently provided update regarding the regulatory pat...

Read More >>
Telix, Grupo RPH ink production & distribution agreement in Brazil

The agreement gives Grupo RPH exclusive right to manufacture and distribute the TLX591-Cdx in the Latin American market Clinical-stage biopharmaceutical firm Telix Pharmaceutical has reportedly signed a manufacturing and distribution agreement with ...

Read More >>
Strides Pharma inks deal with Arrow Pharma to sell Australian business

It had earlier informed it will withdraw its investment in Arrow Pharmaceuticals for an agreed price of AUD 394 million Reports confirm that Strides Pharma Science, a Bangalore based pharmaceutical company, has recently announced that its subsi...

Read More >>
AVITA’s RECELL® System trial on DFU patients yields favorable results

The 26-week observational study included 16 subjects at three different hospitals in the UK Global regenerative medicine company AVITA Medical has recently announced that their open-label study of the latest RECELL® System, conducted on 16 subje...

Read More >>
Accenture to partner with Mujin on digital transformation of logistics

The companies will combine their solution and insights to improve manufacturing productivity Accenture, a multinational services company, recently announced that it is going to collaborate with Mujin, manufacturer of industrial robot controller, in ...

Read More >>
Fushida teams up with Hero Cycles for cycle valley project in India

The Hero Cycles project is scheduled to start manufacturing operations from October 2020 Global bicycle giant Fushida Group has recently announced its partnership with Hero Cycles for a ₹210 crore worth project in the hi-tech cycle valley of ...

Read More >>
Ziopharm concludes enrollment in IL-12 & nivolumab combination trial

Controlled IL-12 platform from Ziopharm is an investigational gene therapy designed to control and induce human interleukin 12 production Ziopharm Oncology Inc, a company that focuses on developing cell therapies and immune-oncology gene, recently a...

Read More >>
NantKwest unveils first-in-human Phase 1 trial of its NK cell therapy

PD-L1 t-haNK is a natural killing cell-based immuno-oncology therapy which includes Chimeric Antigen Receptor (CAR) based on PD-L1 NantKwest, leading company in clinical-stage immunotherapy that develops activated natural killer cells (NK) to treat ...

Read More >>
Beauty retailers fall after Amazon unveils professional beauty store

E-commerce giant Amazon recently announced the launch of Amazon Professional Beauty Store, intended to sell beauty products used by licensed stylists, beauticians & barbers. Followed by the announcement, shares of many specialized beauty retailer...

Read More >>
Parexel unveils new integrated FPS model to boost clinical research

Parexel stands as a pioneer in the delivery and development of a wide range of FSP, with full and flexible clinical development services Parexel, a leading global provider of biopharmaceutical services and innovative therapies, recently announced t...

Read More >>
Delta Air Lines buys 4.3% interest in Korean Air’s owner Hanjin Kal

The agreement is strategically important for Delta to expand outside the U.S. market Delta, a major American Airline, recently announced that it has acquired a 4.3% stake in Hanjin Kal Corp., the parent company of Korean Air Lines Co Ltd., which is ...

Read More >>
UnitedHealth’s bid for DaVita Medical gets conditional FTC approval

Within forty days of closure of the acquisition, UnitedHealth Group would divest DaVita Medical Group’s healthcare provider in Las Vegas UnitedHealth Group has reportedly been granted approval by the Federal Trade Commission for its $4.3 billi...

Read More >>
Rocket Pharma doses first patient in Phase 1 study of Danon treatment

RP-A501 gene therapy can make a significant difference in patients who are suffering from Monogenic Heart Failure Syndrome Rocket Pharmaceuticals Inc, a multi-platform clinical-stage gene therapy company based in the U.S., recently announced that th...

Read More >>
Peraton to acquire innovative IT solutions provider Solers Inc.

Virginia-based Peraton, a defense and intelligence contractor owned by private equity firm Veritas Capital, reportedly announced that it has signed a definitive agreement to acquire Solers Inc., a leading provider of software development and cybersec...

Read More >>
Forty Seven publishes data on Phase 1b/2 clinical trial of 5F9

A clinical-stage immune-oncology company, Forty Seven, Inc., that works to develop therapies targeting cancer immune evasion pathways, has revealed clinical data from Phase 1b/2. The company is evaluating a new drug combination of Recombinant Human A...

Read More >>
FDA grants orphan drug tag to NuCana’s biliary tract cancer treatment

NuCana is on its way to open a Global Phase III study of Acelarin in combination with cisplatin for patients who are suffering from the disease in 2019 NuCana plc recently announced that it has received Orphan Drug Designation for Acelarin, an inves...

Read More >>
Coinbase expands its cryptocurrency debit card to 6 more EU countries

Users are able to spend cryptocurrencies such as Ethereum, Litecoin and Bitcoin in any store or online platform where merchants accept Visa Coinbase, a California based digital currency exchange, recently announced the launch of its crypto debit car...

Read More >>
FDA gives nod to chemoimmunotherapy for patients suffering from DLBCL

Polivy is an innovative antibody-drug conjugate developed with an intention of targeting specific cells Reports confirm that the US Food and Drug Administration has awarded accelerated approval to Polivy (polatuzumab vedotin-piiq), for use in combin...

Read More >>
Dance Biopharm unveils positive Phase 2 trial data for inhaled insulin

The new data further supports the potential of Dance 501 inhaled insulin in Type 2 diabetes patients Dance Biopharm Holdings, Inc has recently presented Phase 2 Samba 04 clinical study results for its preservative free inhaled human insulin, Dance 5...

Read More >>
Takeda Pharma unveils new TOURMALINE-AL1 Phase-3 clinical trial update

· The company announced that the clinical trial failed to fulfil the first of the two preestablished endpoints. · Citing the result of the analysis, Takeda Pharma has decided to permanently halt the trial. Takeda Pharmaceutical Compan...

Read More >>
Walmart partners with MediLedger to track pharmaceutical supplies

MediLedger is preparing to launch its pilot alongside the U.S. FDA to try and reach the 2023 target to deliver a digitized system for tracking and verifying prescription drugs. Global retail giant, Walmart Inc. is reportedly expanding its block...

Read More >>
REGENXBIO announces completion of phase I/IIA RGX-314 clinical trial

Every subject received one dose of RGX-314 managed by subretinal delivery. The leading clinical-stage biotechnology company REGENXBIO Inc. has recently announced that it has finished dosing across all 5 cohorts in the Phase I/IIa medical trial of RG...

Read More >>
Eve & Co confirms second German supply deal for sale of dried cannabis

It expects to begin shipments following the estimated Q2 2019 completion of its 780,000 square foot greenhouse extension Eve & Co has recently announced that Natural MedCo Ltd, its wholly owned subsidiary has entered into a second binding non-ex...

Read More >>
CA-based XStream Trucking bags $10.5 million in Series A funding

The investment will be used to enhance XStream’s ability to deliver better fuel-efficiency to the U.S. trucking industry by means of innovative hardware & software solutions. Renowned vehicle design & engineering company, XStream Truck...

Read More >>
Treos Bio announces results from trial of precision cancer vaccine

Preliminary outcomes of the first part of the study have been made available and results of the second part are anticipated to be published in the third quarter of this year. The immuno-oncology company Treos Bio Ltd. has reportedly announced the po...

Read More >>
TaniGroup raises $10M in a funding round led by Openspace Ventures

TaniGroup runs an agriculture marketplace called TaniHub, and peer-to-peer lender named TaniFund. Indonesia-based TaniGroup has reportedly raised $10 million in Series A funding round which was led by Openspace Ventures in the latest deal in the ag...

Read More >>
Google to shut down the standalone YouTube Gaming App on May 30

The application was launched back in 2015 and was Google’s attempt to with the growing popularity of Twitch. The decision to shut down the standalone application comes as the company has already moved the app’s features to the original...

Read More >>
Novartis grants milestone payment to Cadent for Phase 2 MIJ821 trial

MIJ821 is a potent and selective NMDA receptor modulator being developed for the treatment of treatment-resistant depression Cadent Therapeutics, a precision neuroscience company, has recently announced that it has received the second milestone paym...

Read More >>
89bio reports positive data from Phase 1 clinical trial of BIO89-100

A clinical-stage biopharmaceutical company, 89bio LTD that focusses on NASH (nonalcoholic steatohepatitis), liver and other metabolic disorders, recently announced positive results from Phase 1 SAD (single ascending dose) study on healthy volunteers ...

Read More >>
UDG Healthcare acquires Incisive Health and Putnam Associates

Both acquisitions are good cultural & strategic fit and meet the company’s financial hurdle rates while further expanding its current capabilities. UDG would be financing both transactions from its existing cash & debt facilities. ...

Read More >>
SpringWorks begins Phase 3 trial of desmoid tumor treatment in adults

The company is looking forward to enrolling patients with desmoid tumors to confirm the clinical benefits of nirogacestat SpringWorks Therapeutics, a clinical-stage biopharmaceutical company, has reportedly announced the beginning of Phase 3 “...

Read More >>
Exelixis & Iconic Therapeutics ink exclusive license and option deal

The exclusive license & option agreement has been signed for a new Antibody-Drug conjugate program.   The program, named ICON-2, specifically targets Tissue Factor and would have a potential broad impact on oncology. Exelixis, Inc., (E...

Read More >>
JD.com invests $55 million to foster connected vehicle fleets

The launch of logistic service has begun to reap early rewards regarding cost saving. The long-time rival of Alibaba and Amazon, JD.com, has reportedly announced to invest 376 million yuan (around $55 million) in Jiangsu Xinning Modern Logistics to ...

Read More >>
Vodafone to sell NZ business to Infratil Brookfield in US$2.36B deal

Vodafone is seeking to consolidate its businesses in New Zealand and Australia It had tried to sell Vodafone NZ to satellite TV provider Sky Network in 2017 Reports confirm that Vodafone Group Plc, the British multinational telecommunications congl...

Read More >>
SK Telecom partners with Microsoft on 5G, AI and cloud technologies

Microsoft and SK Telecom have reportedly signed a business partnership in February for cooperation in the smart factory business. SK Telecom recently announced that it has signed a memorandum of understanding (MoU) with Microsoft, the American techn...

Read More >>
Netflix acquires StoryBots to bring educational content to kids

Season 3 of “Ask the StoryBots” would be launched on Netflix in the fall. The American media services provider Netflix Inc. has reportedly announced that it has acquired StoryBots, children's educational media franchise, to bring ed...

Read More >>
China startup Megvii secures $750m funding for AI-powered solutions

The round brings Megvii’s valuation to more than $4 billion ahead of a planned initial public offering (IPO) in Hong Kong Reports confirms that Megvii Technology, a Chinese artificial intelligence provider also known as Face++, has recently se...

Read More >>
Merck unveils Phase 3 data for BELSOMRA C-IV in treatment of insomnia

It is the first dedicated Phase 3 polysomnography study for the treatment of insomnia in people having mild-to-average Alzheimer’s disease and dementia Pharmaceutical company Merck, also known as MSD outside Canada and the United States, has r...

Read More >>
Unichem Lab gets tentative nod from USFDA for hydrochloride medicines

These tablets are indicated for nasal decongestant and antihistamine Unichem may produce and market the generic drug products after approval Reports confirm that Unichem Laboratories has been granted a tentative ANDA approval by the United States F...

Read More >>
Roche, Bio-Techne extend collaboration over mRNA ISH tissue analysis

Roche’s new detection kits have more translucent dyes which are suited for mRNA ISH co-localization studies Swiss healthcare company Roche has recently announced that it has expanded its collaboration with Bio-Techne by providing drug discover...

Read More >>
Esperion confirms FDA acceptance of two NDAs for regulatory review

The NDAs are for oral therapies developed as medication for patients with raised LDL-C who require additional LDL-C lowering Esperion has recently announced that the U.S. Food and Drug Administration has officially accepted both bempedoic acid &...

Read More >>
Sinclair to buy 21 Disney Sports networks in a deal worth over $10bn

Sinclair Broadcast Group, the American telecommunications giant, has reportedly reached a deal worth over $10 billion in order to purchase as many as 21 regional sports networks from the entertainment conglomerate, The Walt Disney Company. The lates...

Read More >>
Innovation Pharma obtains FDA guidance for Brilacidin Phase 3 program

Brilacidin oral rinse is supposedly being developed as part of FDA Fast Track designation for Oral Mucositis Reports confirm that Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, has recently received End-of-Phase 2 meeting mi...

Read More >>
TAQAs ADC to acquire Middle East drilling rigs of Schlumberger

The acquisition has followed on from fast-tracked expansion activity of ADC in 2018. Saudi Arabia's Industrialisation and Energy Services Company (TAQA), has reportedly announced that Arabian Drilling Company (ADC), its drilling subsidiary, has ...

Read More >>
Belite Bio’s IND for LBS-008 gets FDA approval for Phase 1 trial

Drug development company, Belite Bio’s Investigational New Drug application for LBS-008 (BPN-14967), developed to treat AMD and Stargardt disease, has reportedly been approved by the U.S. Food and Drug Administration.  As per trusted sour...

Read More >>
Xcel Energy acquires two wind farms in South Dakota & Minnesota

The move comes as part of Xcel’s strategic plans to deliver 85% carbon-free electricity in the Upper Midwest region by 2030. U.S. electric services company, Xcel Energy Inc. has recently completed the purchase of two wind energy projects ...

Read More >>
Leeward successfully completes full-scale repowering of Mendota farm

Through the farm’s construction phase, Leeward managed to generate close to 250 jobs. North American renewable energy company Leeward Renewable Energy has apparently completed the full-scale repower of the Mendota Hills Wind Farm. If reports a...

Read More >>
Cortexyme launches GAIN Trail to study COR388’s effects on Alzheimer s

Cortexyme, Inc. has reportedly launched the GAIN Trial, a worldwide Phase 2/3 clinical trial of COR388, the company’s lead investigational drug, in patients suffering from mild to moderate Alzheimer’s disease. The first wave of trial site...

Read More >>
BASF, Qatargas ink technology license deal for new LNG trains in Qatar

BASF aims to support Qatargas in achieving its sustainability targets by offering its technologies Gas treatment and gas removal technology play a vital part in LNG production Reports confirm that Qatargas Operating Company Ltd., which is headquart...

Read More >>
Quanta’s SC+ HFT results published in Hemodialysis International

The results from the SC+ HFT with patients as well as healthcare professionals prove that SC+ is easy to use even with a significant learning decay period and minimal training. UK-based medical technology company Quanta Dialysis Technologies Ltd., h...

Read More >>
Otonomy begins OTO-313 Phase 1/2 clinical study for tinnitus patients

Results from the trial are expected in the first half of 2020 and the information would be used to design and plan any further clinical development Biopharmaceutical firm Otonomy, Inc., has reportedly initiated the Phase 1/2 clinical trial of OTO-31...

Read More >>
Mozilla adds option on Firefox to block hidden cryptomining scripts

The browser would leverage a new blacklist of websites which are recognized as using scripts for cryptomining or fingerprinting Reports suggest that Firefox’s upcoming release would provide users the option to block two increasingly common nui...

Read More >>
RealNetworks to integrate SAFR™ with live video management software

SAFR™ for Security delivers high-performance and has remarkably accurate facial recognition to help security teams in protecting facilities, people and assets more effectively RealNetworks, Inc., a leading digital media services and software c...

Read More >>
I-Mab and Jiangsu Nhwa collaborate with Biodextris and Ann Romney CND

The strategic partnership is aimed at jointly developing a new immuno-stimulatory therapy for certain neurologic disorders. I-Mab Biopharma, a Shanghai-based biotech company, along with the CNS (Central Nervous System) drug development company Jiang...

Read More >>
Vattenfall, Boliden ink deal for electrification of mines, smelters

The companies will develop business solutions that include solar panels, batteries, recycling of new generation car batteries and electric transport Reports confirms that Vattenfall and Boliden have entered into an agreement to jointly assess the te...

Read More >>
Grow Biotech, IPS Specials join forces to offer medicinal cannabis

A joint venture will combine IPS Specials’ abilities as a licensed pharma importer with medical cannabis expertise of Grow Biotech Reports confirm that IPS Specials and Grow Biotech will ink a joint venture agreement for creating a new firm th...

Read More >>
Innate Pharma features innovative cancer immunotherapies at AACR 2019

New data describes that a combination of Innate’s anti-CD39 monoclonal antibody and ATP-inducing oxaliplatin had enhanced the control of tumor growth Innate Pharma has reportedly announced that new preclinical data from the innovative portfoli...

Read More >>
FDA’s new mammography proposal to help enhance diagnosis accuracy

The FDA (Food & Drug Administration) has reportedly proposed a new rule that would require mammography providers to inform female patients with dense breast tissue about the fact that the condition may impact the accuracy of their mammograms. The...

Read More >>
WatchGuard establishes office in Noida, India to expand R&D operations

This office signifies the latest investment from the company into its aggressive IT Development initiatives   An important focus for its team would be for driving the R&D for new WatchGuard Cloud platform features WatchGuard Technologi...

Read More >>
NuMSP announces acquisition of Corporate Technologies Boise business

The company is looking to provide services nationwide with efficient scale and resources to deliver advanced IT services to SMBs NuMSP, one of the leading national managed service providers (MSP) which offers cybersecurity and IT solutions in the ma...

Read More >>
Bettcher Industries to buy renowned manufacturing company Cantrell

Bettcher Industries Inc. has reportedly announced its acquisition of the U.S.-based Cantrell, which manufactures equipment & systems for the poultry-processing industry. Apparently, Bettcher Industries looks to offer a broader line of innovative ...

Read More >>
Vietnams FastGo expands into Singapore’s ride-hailing market

The startup will offer cheaper ride fares than its rivals and will not charge surcharges during peak hours in the country. Vietnamese ride-hailing startup, FastGo has recently announced that it will launch its services in Singapore startin...

Read More >>
Aerie Pharmaceuticals commences Phase 2 clinical trial of AR-1105

AR-1105 is an intravitreal, fully bio-erodible PRINT-manufactured implant that releases steroid dexamethasone. Aerie Pharmaceuticals, an ophthalmic pharmaceutical company, has reportedly initiated the Phase 2 clinical trial evaluating AR-1105 for in...

Read More >>
Merck’s KEYTRUDA ® wins EC approval for treatment of NSCLC patients

KEYTRUDA® combination significantly improved overall survival in adults with metastatic squamous NSCLC   Its safety in combination with chemotherapy was evaluated in 791 NSCLC patients in clinical studies Merck has recently announced t...

Read More >>
Facebook, WhatsApp & Instagram suffer outages across Europe & Americas

Facebook & its four primary smartphone applications have been suffering from severe outages throughout the world since March 13, 2019, 12 pm EST.   While the outage was the longest ever experienced by the social media giant, company spok...

Read More >>
Almac Group unveils Almac One solution for clinical trial supply chain

Almac One™ would help sponsors to face the challenges existing in the drug development market It provide a single set of process to sponsors and enable greater visibility and control of supply chain Reports confirm that Almac Group has recent...

Read More >>
GE Healthcare and Adventist sign performance enhancement collaboration

The five-year collaboration is expected to bring about financial improvement amounting to almost $100 million. GE Healthcare and Adventist Health, two of the most renowned healthcare providers in the U.S. recently announced that in a collaboration t...

Read More >>
BioXcel adds Pfizer, Merck to pancreatic cancer therapy collaboration

BioXcel Therapeutics, Inc. has made an announcement confirming the addition of Germany-based Merck KGaA as well as Pfizer Inc. to its clinical collaboration with Nektar Therapeutics for evaluating an innovative triple combination treatment for pancre...

Read More >>
Novartis data confirms rapid response of Cosentyx® in China study

The study proves to offer clear or almost clear skin in 8/10 patients within 16 weeks of Cosentyx® 300mg treatment. Swiss pharmaceutical major, Novartis AG (NVS) has recently announced that its data from a Phase III study conducted on 441 Chines...

Read More >>
Verrica announces positive results for molluscum contagiosum treatment

The treatment would help to address unmet medical needs against serious skin lesions Reports suggest that the lead candidate of Verrica Pharmaceuticals, a drug-device combination for dermatology indication, has achieved primary endpoints in two of t...

Read More >>
Hua Medicine confirms patient enrollment for study of diabetes drug

Shanghai-based drug development firm Hua Medicine, which focuses on developing global first-in-class oral drug for treating Type 2 diabetes, has recently announced that it has completed patient enrollment for a Phase III monotherapy trial of dorzagli...

Read More >>
OneWeb inks two deals to deliver high speed communications services

The announcement was made the company at Mobile World Congress 2019 which is being held in Barcelona   The company has signed two separate contracts with OneWeb and Intermatica The U.S. based satellite communications firm OneWeb has report...

Read More >>
OneWeb inks two deals to deliver high speed communications services

The announcement was made the company at Mobile World Congress 2019 which is being held in Barcelona The company has signed two separate contracts with OneWeb and Intermatica The U.S. based satellite communications firm OneWeb has reportedly ann...

Read More >>
Sarepta to buy Myonexus to expand muscular dystrophy therapy portfolio

Sarepta Therapeutics has recently confirmed that it is planning to acquire Myonexus Therapeutics in a $165 million deal, by exercising a purchase option that was part of a gene therapy partnership commenced by the firms in the previous year. The tra...

Read More >>
Scholar Rock’s Phase 1 study of SRK-015 delivers positive interim data

Scholar Rock Holding Corporation, the clinical-stage biopharma company focusing on treating serious diseases which are affected by protein growth factors, has recently confirmed positive interim results for its Phase 1 multiple and single-ascending d...

Read More >>
Ocutrx develops advanced Oculenz AR glasses with eye-tracking ability

California-based augmented reality (AR) glasses manufacturer, Ocutrx Vision Technologies, LLC, has recently unveiled its new, cutting-edge design for Oculenz™ AR Wear glasses, which is the company’s flagship product. Sources with knowled...

Read More >>
ZEDEDA announces close of $16 million Series A funding round

The funding is to support the company’s vision of creating an ultra-secure, open-source and standards-based cloud-native edge. ZEDEDA, one of the leaders in edge virtualization software announced that the company has recently secured a substan...

Read More >>
Microsoft, Telefonica announce new AI and edge computing partnership

Telefónica will expand the use of Microsoft’s Azure Cognitive Services over all customer relationship channels The companies will also work to develop Telefónica’s smart applications for connected home devices Microsoft Co...

Read More >>
Morphic to collaborate with Janssen to develop integrin therapeutics

Morphic has attained leadership position in the development of oral integrin inhibitors with the help of the ground-breaking structural research Morphic Therapeutic, the Massachusetts-based biotechnology company recently announced that it has entere...

Read More >>
Facebook updates location settings, adds privacy controls on Android

A few Android users had expressed concern over the app’s capability to continuously record location data in the background Facebook has previously tracked the location of users deemed to be threats Social media giant Facebook has reportedl...

Read More >>
JAYS Group to acquire connected audio and speaker brand CLINT® Digital

Premium headphones and app company, JAYS Group AB, has reportedly entered into a binding agreement for acquiring CLINT® Digital, the award-winning lifestyle audio brand from Denmark. The CLINT® brand, to become a part of JAYS Group organizati...

Read More >>
AzurRx doses first patients in Phase II OPTION study for EPI therapy

AzurRx BioPharma, Inc. has recently informed that the company has dosed the first patients in its Phase II OPTION clinical study aimed at investigating MS1819-SD in cystic fibrosis (CF) patients who experience exocrine pancreatic insufficiency (EPI)....

Read More >>
Philippines FDA bans Sanofis dengue vaccine due to compliance issue

Reports confirm that the Philippines has revoked the product license for Dengvaxia, the dengue vaccine from Sanofi, after the France-based pharmaceutical company failed to comply with directives of regulators. Apparently, the sale, distribution and m...

Read More >>
CASI Pharma gets NMPA’s nod to conduct confirmatory trial of ZEVALIN®

The firm previously secured greater China rights to ZEVALIN® from Spectrum and aims to launch ZEVALIN® in the country. CASI Pharmaceuticals is currently addressing certain stipulations prescribed by the Center for Drug Evaluation (CDE) &n...

Read More >>
Inventiva declares results of Phase IIb clinical trial of lanifibranor

The FASST clinical trial failed to meet its primary endpoint of a mean absolute change from baseline to week 48 The French clinical-stage biopharmaceutical firm Inventiva has reportedly declared the results from the ‘For A Systemic Sclerosis T...

Read More >>
Miromico, Renesas unveil partnership to produce new LoRa-based module

Miromico and Renesas have recently confirmed that the companies have collaborated and produced a low-power and compact FMLR-61-x-RSS3 module that will allow customers to connect to LoRaWAN-based networks easily. The module is reportedly based on LoRa...

Read More >>
SoftBank invests in a new USD 400m European tech fund of Mubadala

Mubadala would use the fund to invest between USD 5 million and USD 30 million in European technology startups Japans conglomerate SoftBank Group has reportedly announced to have invested nearly half the amount for the recently launched USD 400 mill...

Read More >>
Mitsubishi Corporation invests in UK-based energy tech firm OVO Group

Mitsubishi Corporation would obtain 20 percent shares in the firm   The conglomerate would appoint a director on the management team of OVO Group Japanese conglomerate Mitsubishi Corporation has reportedly declared that it has invested in ...

Read More >>
Merck presents data from new Phase 3 trials to treat mCRPC patients

Pharmaceutical major Merck & Co Inc., has apparently announced the launch of three late-stage studies for KEYTRUDA – its cancer immunotherapy. Trusted reports cite that these studies are being introduced as a combination treatment for the m...

Read More >>
Life science firm Jubilant & Sanofi collaborate on CNS therapeutics

Jubilant will deliver Sanofi drug discovery services with its integrated drug discovery platform. The Bengaluru-based arm of the reputed Jubilant Life Sciences, Jubilant Biosys, has apparently declared that it has signed an integrated drug discovery...

Read More >>